Log in or subscribe to view full content. Article is also available for purchase the article in one of the available formats.
188548 items (188548 unread) in 47 feeds
World Health Organization
(225 unread)
Media
(145920 unread)
Bird Flu
(3037 unread)
Diabetes
(8383 unread)
Cholesterol
(3552 unread)
Cancer
(15070 unread)
HIV
(7233 unread)
Women
(3799 unread)
Men
(1329 unread)
Cholesterol (60 unread)
Log in or subscribe to view full content. Article is also available for purchase the article in one of the available formats.
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia SAN DIEGO-- --Santarus, Inc.
When I was getting my degree in exercise science, one of the things we learned how to do is an exercise stress test with an ECG .
Forget the oysters and the champagne this Valentine's Day. If you want to keep your true love's heart beating strong, dark chocolate and red wine are the food and drink of love, said Susan Ofria, clinical nutrition manager at Gottlieb Memorial Hospital.
I'm aged 43 and have been taking simvastatin for seven months due to high cholesterol.
Most of us can recognize the difference between a brand name product and a non-brand named or generic product.
You have to know the high cholesterol symptoms as it is very important for you. Cholesterol is such a nutrition element, which is needed for the proper growth of a human body.
Q: High bad cholesterol, low good cholesterol, Off Lipitor due to severe loss of muscle, what foods or supplements should I take? Important: We hope you find this general health information helpful.
On February 2, 2012, Mylan Inc. announced the tentative U.S. Food and Drug Administration approval of Atorvastatin Calcium.
Merck & Co. swung to a fourth-quarter profit because of lower restructuring and other charges and higher sales of most of its key drugs.
THURSDAY, Feb. 2 -- Be wary of buying the cholesterol-lowering drugs known as statins on the Internet, British researchers say.
The bottom line is usually the one to watch. But not for AstraZeneca. On Thursday, the British drug maker announced a 7 per cent increase in earnings per share before exceptional items.
Merck & Co. Inc. is set to take such a hit in the second half of 2012. and Lilly, which reported steep declines in their fourth-quarter profits, experienced the initial impact from generics since they lost U.S. patent protection on several of their top-selling treatments.
Generic drugmaker Mylan Inc. said Thursday that the Food and Drug Administration tentatively approved several pill sizes of the company's generic version of cholesterol fighter Lipitor, the world's top-selling drug.
February is American Heart Month. For many years doctors and nutritionists have preached to cut red meat from the diet to improve heart health, but now new research shows that a moderate amount of lean beef is not only acceptable, but actually beneficial.
For the past several years, drug industry experts have spoken in terms of the "patent cliff," the period when the patents covering several blockbuster drugs are set to expire, thus leaving their manufacturers with a big, gaping hole in their revenues as those drugs face competition from generics.
More News in Brief: CT-Scan Dye Can Affect Thyroid; Sex Called Safe for Most Heart Patients; Safety of New Blood Thinner Gets a Closer Look Osteoporosis is a disease that causes bones to become "thin" . It can lead to hip fractures and spine fractures in elderly people.
Research from The Cancer Institute of New Jersey on the FDA-approved drugs Celebrex A and Lipitor A -- used respectively for arthritis pain and lowering cholesterol -- shows that these drugs are well tolerated in the treatment of recurrent prostate cancer .
Pfizer Inc., issuing its first financial report since losing patent protection on blockbuster cholesterol drug Lipitor, said today that adjusted earnings in the fourth quarter rose 6 percent.
Doctors are more likely to give cholesterol drugs known as statins to men. But a new study, published in the Jan.
PROFIT DIVE: Drugmaker Pfizer's fourth-quarter net income fell by half, to $1.44 billion, or 19 cents per share, because of charges and new generic competition for Lipitor, the blockbuster cholesterol-lowering drug.
Drugmaker Merck & Co., the world's third-biggest drugmaker by revenue and a Dow component, will tout recent drug approvals and progress on creating new drugs when it reports its fourth-quarter results before the stock market opens Thursday.
Pfizer Inc. said Tuesday that its fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol drug Lipitor losing patent protection.
A view of the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels in this January 23, 2007 file photo.
Pfizer Inc.'s fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol drug Lipitor losing patent protection.
Dear Dr. Donohue: I am a 69-year-old woman and take simvastatin and alendronate.
MONDAY, Jan. 30 -- Cholesterol-lowering drugs known as statins are equally effective in men and women, a new study finds.